NIH-funded research NIH-funded research

Developing predictive biomarkers for early disease detection

Official title: Administrative Core

Funded at New York University School of Medicine · NIH-11081757 · Data updated 2026-11-12

This study is working on developing reliable tests that can help find cancer early, so patients can get the right treatment sooner, and it brings together different cancer centers to share information and improve these tests.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startMay 4, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$339,875
NIH project number5U2CCA271890-03
Project IDNIH-11081757 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for diseases that can be detected through biomarker testing.

Less likely to help

Patients with conditions that do not involve detectable biomarkers or those not at risk for the targeted diseases may not benefit from this research.

What this research studies

This research focuses on creating and validating highly predictive biomarkers that can be standardized into clinical assays for early disease detection. The project aims to establish a robust infrastructure for data integration and collaboration among various cancer centers and laboratories. By coordinating efforts and sharing findings, the research seeks to enhance the accuracy and efficiency of biomarker development, ultimately improving patient outcomes. Patients may benefit from advancements in early detection methods that could lead to timely interventions.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and earlier detection of diseases, improving treatment outcomes for patients.

How similar studies have gone: Previous research has shown success in developing predictive biomarkers for early disease detection, indicating a promising avenue for this approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Segal, Leopoldo Nicolas — New York University School of Medicine
  • Study coordinator: Segal, Leopoldo Nicolas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.